KalVista Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KALV and other ETFs, options, and stocks.About KALV
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa.
KALV Key Statistics
Stock Snapshot
As of today, KalVista Pharmaceuticals(KALV) shares are valued at $16.53. The company's market cap stands at 851.45M, with a P/E ratio of -4.04.
On 2025-12-10, KalVista Pharmaceuticals(KALV) stock traded between a low of $15.88 and a high of $17.08. Shares are currently priced at $16.53, which is +4.1% above the low and -3.2% below the high.
The KalVista Pharmaceuticals(KALV)'s current trading volume is 878.29K, compared to an average daily volume of 1.79M.
In the last year, KalVista Pharmaceuticals(KALV) shares hit a 52-week high of $17.28 and a 52-week low of $7.30.
In the last year, KalVista Pharmaceuticals(KALV) shares hit a 52-week high of $17.28 and a 52-week low of $7.30.
KALV News
In the last year, many KalVista Pharmaceuticals, Inc. ( ) insiders sold a substantial stake in the company which may have sparked shareholders' attention. When...
